STRS Ohio’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

STRS Ohio’s Portfolio LABP Stock Details LABP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,140	Closed	-$16K	–	2369
2022 Q1	$16K	Hold	1,140	–	–	﹤0.01%	2064
2021 Q4	$54K	Hold	1,140	–	–	﹤0.01%	1997
2021 Q3	$166K	Buy	1,140 +990	+660%	+$129K	﹤0.01%	1821
2021 Q2	$17K	Hold	150	–	–	﹤0.01%	2184
2021 Q1	$14K	Buy	+150	New	+$19.6K	﹤0.01%	2118

Other funds holding LABP

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio's LABP Position: Q2 2022 in Review

STRS Ohio sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2022, closing a stake of 1,140 shares — an estimated $16K sold.

STRS Ohio first reported a position in LABP in Q1 2021 and held it in 5 quarters. The position peaked at $166K in Q3 2021. 34 funds tracked by Wall St. Rank hold LABP as of Q2 2022.

STRS Ohio reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 1,140 Landos Biopharma, Inc. Common Stock shares in Q2 2022, an estimated $16K.
STRS Ohio first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
STRS Ohio's Landos Biopharma, Inc. Common Stock position peaked at $166K in Q3 2021.
34 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.